MedPath

Benzoyl peroxide

Generic Name
Benzoyl peroxide
Brand Names
Acanya, Aktipak, Benzac, Benzaclin, Benzamycin, Benzefoam, Benzepro, Cabtreo, Clean and Clear, Clean and Clear Advantage Mark Treatment, Clearasil, Clindoxyl, Duac, Epiduo, Epsolay, Neobenz Micro Wash, Neuac, Onexton, Oxy Daily Wash, Panoxyl, Persa-gel, Relovox, Riax, SkinMedica Acne Treatment, Tactupump, Twyneo, Vanoxide-HC
Drug Type
Small Molecule
Chemical Formula
C14H10O4
CAS Number
94-36-0
Unique Ingredient Identifier
W9WZN9A0GM

Overview

Benzoyl peroxide is a commonly used drug in topical treatments for acne. It has been formulated as products with either a single active ingredient, or with erythromycin, clindamycin, or adapalene. After administration, the peroxide bond is cleaved, allowing benzoyloxy radicals to nonspecifically interact with proteins. This treatment decreases keratin and sebum around follicles, as well as increasing turnover of epithelial cells. Benzoyl peroxide, in combination with erythromycin, was granted FDA approval on 26 October 1984.

Background

Benzoyl peroxide is a commonly used drug in topical treatments for acne. It has been formulated as products with either a single active ingredient, or with erythromycin, clindamycin, or adapalene. After administration, the peroxide bond is cleaved, allowing benzoyloxy radicals to nonspecifically interact with proteins. This treatment decreases keratin and sebum around follicles, as well as increasing turnover of epithelial cells. Benzoyl peroxide, in combination with erythromycin, was granted FDA approval on 26 October 1984.

Indication

Benzoyl peroxide is formulated with antibiotics such as erythromycin and clindamycin for the treatment of acne vulgaris. Benzoyl peroxide is formulated as a number of topical products for the treatment of acne. Benzoyl peroxide is also indicated in combination with tretinoin for the treatment of acne vulgaris in patients aged nine years and older. A triple-combination therapy including both clindamycin and adapalene is also available and indicated for the treatment of acne vulgaris in patients ≥12 years of age. Topical benzoyl peroxide is also indicated for the treatment of inflammatory lesions of rosacea in adults.

Associated Conditions

  • Acne
  • Acne Vulgaris
  • Inflammatory Acne Vulgaris
  • Inflammatory lesions caused by rosacea

FDA Approved Products

Clindamycin Phosphate and Benzoyl Peroxide
Manufacturer:Bryant Ranch Prepack
Route:TOPICAL
Strength:25 mg in 1 g
Approved: 2023/07/17
NDC:63629-8635
ADAPALENE AND BENZOYL PEROXIDE
Manufacturer:Alembic Pharmaceuticals Inc.
Route:TOPICAL
Strength:25 mg in 1 g
Approved: 2023/12/11
NDC:62332-662
adapalene and benzoyl peroxide
Manufacturer:Padagis Israel Pharmaceuticals Ltd
Route:TOPICAL
Strength:2.5 g in 100 g
Approved: 2022/10/31
NDC:45802-846
ADAPALENE AND BENZOYL PEROXIDE
Manufacturer:Bryant Ranch Prepack
Route:TOPICAL
Strength:25 mg in 1 g
Approved: 2022/06/02
NDC:63629-9322
Adapalene and benzoyl peroxide
Manufacturer:Zydus Lifesciences Limited
Route:TOPICAL
Strength:25 mg in 1 g
Approved: 2022/06/06
NDC:70771-1716

Singapore Approved Products

EPIDUO GEL 0.1%/2.5%
Manufacturer:LABORATOIRES GALDERMA
Form:GEL
Strength:2.50%
Online:Yes
Approved: 2010/04/21
Approval:SIN13789P
CLINDOXYL Once Daily Gel
Manufacturer:Stiefel Laboratories (Ireland) Ltd, Glaxo Operations UK Limited (trading as Glaxo Wellcome Operations)
Form:GEL
Strength:6.67% w/w
Online:Yes
Approved: 2007/08/07
Approval:SIN13332P
EPIDUO FORTE GEL 0.3%/2.5%
Manufacturer:G PRODUCTION INC, Laboratoires Galderma
Form:GEL
Strength:2.50 %W/W
Online:Yes
Approved: 2018/04/03
Approval:SIN15460P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath